Tekmira to supply Ebola treatment for studies in West Africa

TORONTO (Reuters) - Tekmira Pharmaceuticals Corp will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa by a consortium that includes England's Oxford university, the Canadian company said on Monday. Tekmira said 100 courses of its TKM-Ebola-Guinea treatment will be made available for the studies, and that it has entered into a manufacturing and clinical trial agreement with Oxford. ...

via Health News Headlines - Yahoo News Read More Here..